Anhui Yukang new materials Co., Ltd. plans to build the new project of 19500 MT pharmaceutical intermediates per year in Huaishang Economic Development Zone, Bengbu, Anhui Province. The controlling shareholder of Anhui Yukang is Anhui Sealong Biotechnology Co.,Ltd.
The project covers an area of 10 hectares, with a total construction area of 57000 square meters. The project will be implemented in two phases, with an annual production capacity of 19500MT pharmaceutical intermediates.
The main products of phase I include pantolactone (6000MT / year) and derivative products (4500 MT/ year). By products are ammonium sulfate and ammonium chloride. It is expected to be put into operation in October 2020.
The main products of phase II include high purity amino acid (2000MT / year), imidazole (2000 MT/ year) and NBSA (5000 MT/ year). By products are sodium sulfate and sodium bisulfite. It is expected to be put into production in October 2021.